...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Data Expected September 2019 for BETonMACE Phase 3 Cardiovascular Outcomes Trial for Apabetalone

Message: Opportunity Knocks

.....and if topline is +ve then a US listing of some sort won’t be far behind.

New Message
Please login to post a reply